ArticleAlzheimer's research & therapy2025
Baseline and follow-up change of cholesterol levels predict dementia risk and progression in older adults: a U-shaped relationship.
Article in Alzheimer's research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Low-Density Lipoprotein Cholesterol and Dementia Risk: Integrating Mendelian Randomization and Target Trial Emulation Within the Heart-Brain Axis.medRxiv : the preprint server for health sciences · 2026Article
- Association of cognitive impairment with statin use in coronary artery disease across APO (ε) genotypes in AllofUS.medRxiv : the preprint server for health sciences · 2026Article
- Association of coronary artery bypass with cognitive impairment in coronary artery disease across APO (ε) genotypes in AllofUS.BMJ neurology open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionPrevious studies on serum lipid levels and cognitive outcomes have shown inconsistent results, partly due to differences in timing of lipid assessment, cognitive status, and lack of longitudinal data. This study aimed to examine both baseline and longitudinal changes in lipid profiles in relation to dementia onset and cognitive progression across different stages of cognitive impairment.
methodsA retrospective cohort study was conducted using data from the History-Based Artificial Intelligent Clinical Dementia Diagnostic System (HAICDDS), a multicenter memory clinic registry in Taiwan. Among 2,452 adults aged ≥ 60 years, lipid levels (total cholesterol, low-density lipoprotein cholesterol [LDL-c], high-density lipoprotein cholesterol [HDL-c], and triglycerides [TG]) were assessed at baseline and follow-up. Participants were stratified into subjective cognitive decline, mild cognitive impairment, or dementia. Cox proportional hazards models were used to evaluate associations with incident dementia or cognitive progression.
resultsU-shaped associations were observed between lipid levels and cognitive outcomes. After adjusting for demographic and vascular risk factors, both low baseline values and extreme reductions-particularly in HDL-c and TG-were significantly associated with increased risk of dementia onset or progression.
conclusionLipid instability, especially in HDL-c and TG, may serve as a marker of cognitive vulnerability. These findings suggest that longitudinal changes in serum cholesterol should be carefully monitored in older adults at risk of cognitive decline.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.